KalVista Pharmaceuticals, Inc.
DE ˙ DB ˙ US4834971032
23,01 € 0,00 (0,00%)
2026-06-04
AKTIENPREIS
SecurityDE:4XC1 / KalVista Pharmaceuticals, Inc.
InstitutionInvesco Ltd.
Latest Disclosed Ownership75,282 shares
Latest Disclosed Value $ 1,515,427
Invesco Ltd. reports 3.32% decrease in ownership of 4XC1 / KalVista Pharmaceuticals, Inc.

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 75,282 shares of KalVista Pharmaceuticals, Inc. (DE:4XC1) valued at $1,166,871 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 77,864 shares of KalVista Pharmaceuticals, Inc.. This represents a change in shares of -3.32% during the quarter. The current value of the position is $1,732,239 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 75,282 -2,582 -3.32 1,515 20.53 0.0000
2026-02-19 2025-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 77,864 14,621 23.12 1,258 63.25 0.0002
2025-11-13 2025-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 63,243 12,482 24.59 770 34.38 0.0001
2025-08-13 2025-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 50,761 10,957 27.53 574 24.84 0.0001
2025-05-12 2025-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 39,804 24,164 154.50 459 247.73 0.0001
2025-02-13 2024-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 15,640 1,083 7.44 132 -21.43 0.0000
2024-11-12 2024-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 14,557 277 1.94 169 0.00 0.0000
2024-08-13 2024-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 14,280 308 2.20 168 1.82 0.0000
2024-05-14 2024-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 13,972 495 3.67 166 0.00 0.0000
2024-02-13 2023-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 13,477 13,477 165 0.0000
2023-08-11 2023-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 0 -10,147 -100.00 0 -100.00
2023-05-12 2023-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 10,147 -1,071 -9.55 80 5.33 0.0000
2023-02-13 2022-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 11,218 11,218 76 0.0000
2022-02-14 2021-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 0 -10,222 -100.00 0 -100.00
2021-11-15 2021-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 10,222 -145,618 -93.44 178 -95.23 0.0000
2021-08-17 2021-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 155,840 155,840 3,734 0.0009
2020-08-14 2020-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 0 -10,884 -100.00 0 -100.00
2020-05-15 2020-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 10,884 10,884 83 0.0000
2020-02-14 2019-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 0 -11,257 -100.00 0 -100.00
2019-11-14 2019-09-30 13F KALVISTA PHARMACEUTICALS COM 483497103 11,257 -247,416 -95.65 130 -97.73 0.0000
2019-08-14 2019-06-30 13F/A-1 KALVISTA PHARMACEUTICALS COM 483497103 258,673 -55,118 -17.57 5,729 -36.20 0.0015
2019-08-14 2019-06-30 13F KALVISTA PHARMACEUTICALS COM 483497103 258,673 -102,376 5,729
2019-05-15 2019-03-31 13F KALVISTA PHARMACEUTICALS COM 483497103 313,791 37,268 13.48 8,980 64.44 0.0030
2019-02-14 2018-12-31 13F KALVISTA PHARMACEUTICALS COM 483497103 276,523 276,523 5,461 0.0021
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.